Stereotactic Ablative Radiotherapy for Prostate Cancer-The Treatment Results of 500 Patients and Analysis of Failures.

Leszek MiszczykAgnieszka Namysł-KaletkaAleksandra NapieralskaMałgorzata KraszkiewiczMarcin MiszczykGrzegorz WoźniakMałgorzata Stąpór-FudzińskaGrzegorz GłowackiAndrzej Tukiendorf

Published in: Technology in cancer research & treatment (2020)

CyberKnife-based stereotactic ablative radiotherapy of low-risk and intermediate-risk prostate cancer patients is an effective and well-tolerated modality of treatment. PSA is the most important predictive factor. The evolution of PSA concentration in a particular subgroup of patients suggests that ADT in intermediate-risk cases could improve long-term results.

Keyphrases

prostate cancer
end stage renal disease
radical prostatectomy
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
radiation therapy
locally advanced
randomized controlled trial
clinical trial
patient reported
study protocol
brain metastases
rectal cancer